| 10:30 AM |
Arrival morning tea |
|
|
11:00 AM
|
Opening welcome (MC)
|
Dr Amanda Gillon
Senior Partner, BioScience Managers
|
|
11:05 AM
|
CEO address
|
Yasser El-Ansary
Chief Executive, Australian Investment Council
|
|
11:10 AM
|
Keynote address
|
Samir Kumar
Managing Director, M12 | Microsoft's Venture Capital Fund
|
|
11:45 AM
|
Australia’s billion-dollar quantum computing opportunity
|
Dr Cathy Foley
Australia's Chief Scientist
Dr Michael Hush
Chief Scientific Officer, Q-CTRL
Yasser El-Ansary
Chief Executive, Australian Investment Council
|
|
12:25 PM
|
VC fundraising and investments breaking records all over the world – What happens next?
|
Alicia Gregory
Head of Private Equity, Future Fund
Phil Cummins
Venture Partner, Greenspring Associates
Fred Giuffrida
Managing Director, Horsley Bridge Partners
|
|
01:15 PM
|
Networking lunch
|
|
|
02:00 PM
|
Taking sustainable food production to the mainstream market
|
Nick Hazell
Founder & CEO, v2food
George Peppou
Co-founder & CEO, Vow
Anna Ellis
Investment Director, Roc Partners
|
|
02:35 PM
|
Towards net zero: The intersection of smart technology and renewable energy
|
Mark Woodall
Executive Chairman, GreenSync
Kristin Vaughan
Director - Innovation Fund, Clean Energy Finance Corporation
Justine Jarvinen (JJ)
Chief Executive Officer, UNSW Energy Institute
Christiaan Jordaan
CEO & Founder, Sicona Battery Technologies
|
|
03:15 PM
|
Afternoon tea
|
|
| 03:40 PM |
Key government policy reforms aimed at growing Australia’s innovation ecosystem
|
Brendon Harper
Head of Policy and Research, Australian Investment Council
Robyn Tolhurst
Public Affairs Manager, Australian Investment Council
|
| 04:10 PM |
Heading for the exit door: key considerations for VC managers and their investors |
James Posnett
Senior Manager, Listings Business Development, ASX
Dean Dorrell
Partner, Carthona Capital
Stephen Dash
Founder & CEO, Credible
|
| 04:45 PM |
The ACCC is nervous about FinTech businesses being bought out by big banks – do we have a problem? |
Todd Forest
Managing Director, NAB Ventures
Simon Cant
Co-founder & Managing Partner, Reinventure
Prudence Smith
Partner, Jones Day
|
| 05:20 PM |
Will the development of COVID-19 vaccines forever change the speed of new drug discovery processes? |
Dr Anand Gautam
Executive Director & Emerging Science Lead, Pfizer
Dr Amanda Gillon
Senior Partner, BioScience Managers
|
| 05:50 PM |
Closing remarks |
|
| 05:55 PM |
Networking drinks & canapés |
|
| 07:30 PM |
Close |
|